A director at Floridienne S.A. sold 74 shares at 750.000EUR and the significance rating of the trade was 54/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two years clearly s...
Floridienne announced that its subsidiary Biobest , a world leader in pollination and integrated pest management (IPM), will acquire Brazilian Biotrop from Aqua Capital and GIC investment funds. This large-scale transaction gives Biobest a significant position in South America and allows it to expand its range of biological solutions, which will now include biocontrol (beneficial insects and biopesticides), inoculants, biostimulants and pollination for both greenhouse crops, Biobest's traditiona...
One year after our 'Hydrogen Primer' we now take a closer look into the energy transition as we are analysing how we are doing on our "Road -or should we say Race- to Net Zero". Global temperatures are at a record high, with the Earth 1.1°C warmer than preindustrial levels. To limit the increase below 1.5°C, emissions must be reduced by 45% by 2030 and reach Net Zero by 2050. Current commitments fall short of these targets. We highlight that achieving Net Zero will require substantial financia...
Diverging performances. Over the first half of the year, brewers were largely able to offset higher raw material costs by higher revenue per hl (price increases, premiumization, channel mix) in absolute terms, although gross margins were under pressure. AB InBev, Carlsberg and Heineken additionally cut into operating expenses allowing the groups to record operating profit growth of respectively 7.5%, 31.8% and 24.6%. Molson Coors and Royal Unibrew were slower off the mark and consequently suffer...
AB INBEV - BUY | EUR65(+22%) When high debt is no longer a liability Ever since the acquisition of SABMiller, AB InBev’s debt levels have been a worry for investors, reflected in a higher risk premium and lower valuation. However, in the current high-inflation environment, AB InBev’s debt is a significant source of value creation. While inflation increases top-line and profit figures, it decreases the value of debt. And no other beverages company has the same high debt levels as AB InBev (net...
Today we update our Dynamic Top Pick List : • We ADD : None • We REMOVE : Fugro • We KEEP Large Caps: AB Inbev, Ageas, Ahold Delhaize, ArgenX, ASML, bpost, D'Ieteren, Telenet, UCB and Umicore. • We KEEP Mid Caps: Care Property Invest, EVS, Intervest Offices and Warehouses, Kinepolis, Materialise,TINC and X-fab. Performance: In the previous month our Dynamic Top Pick List lost month-to-month 4.61% and ended a series of outperformance. We outperformed the BEL-20 by 0.6%, but underperformed the...
AB INBEV - BUY TOP PICKS | EUR65 Q1 revenue growth of 11.1% - full year outlook confirmed Q1 revenue growth of 11.1% and EBITDA growth of 7.4% Brazil revenues grew strongly but there was expected weakness in both the US and China Outlook confirmed – revenue growth ahead of EBITDA growth of between 4 and 8%
AB InBev: 1Q EBITDA +7.4%, FY guidance of +4-8% kept Argenx: Q1 results: The commercial rise of Vyvgart CFE: DEME: preparing for US offshore wind market ForFarmers: Substantially higher prices for raw materials IBA: Receives first order from CGNNT for a P+ solution IO&W: 1Q22 – Lease cancellation boosts profit Recticel: Baltisse acquires additional 4.36% call option Sofina: Price Correction Presents Favourable Entry Point Ter Beke: Next steps in important acquisition process Various: DTPL – Feed...
Today we update our Dynamic Top Pick List : • We ADD : Sofina • We REMOVE : None • We KEEP Large Caps: AB Inbev, Ageas, Ahold Delhaize, ArgenX, ASML, bpost, D'Ieteren, Telenet, UCB and Umicore. • We KEEP Mid Caps: Care Property Invest, EVS, Fugro, Intervest Offices and Warehouses, Kinepolis, Materialise,TINC and X-fab. Performance: In the previous month our Dynamic Top Pick List was month-to-month nearly flat outperforming our benchmark indices (AEX, Bel20 & Stoxx50) on average an impressive...
AB InBev: Preview 1Q21: top line to be supported by pricing Biotalys: FRAC granted Evoca’s active ingredient a new class DSM: 1Q EBITDA +10%, FY guidance reiterated Euronav: Note: Clash – or reconciliation? – of the Titans IBA: Acquires Modus Medical Devices Mithra: The era of E4 Solvay: Preview 1Q: 5% underlying EBITDA growth expected UCB: Fintepla Phase 3 trial data published
Unfortunately, this report is not available for the investor type or country you selected.
Report is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.